How many institutions held VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in Q4 2019?

52 institutional investors reported VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value for Q4 2019. Use the holders table for investor-level position and value details.

Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)

Q: What does CUSIP 92511W108 represent in this 13F holders report?

CUSIP 92511W108 is the security identifier for VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

CUSIP: 92511W108

Q4 2019 13F Holders as of 31 Dec 2019

Security type / class: Equity / Common Stock, $0.0001 par value
Total 13F shares: 9,202,752
Total 13F value: $144,059,393
Share change: -271,555
SEC-reported price per share: $15.89
Number of holders: 52
Value change: -$4,086,412
Number of buys: 31
Number of sells: 10
Shares outstanding: 92,448,158

Security key

92511W108

Report period

Q4 2019

Institutions

Top holders

VRCA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Verrica Pharmaceuticals Inc. SEC filings Verrica Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 92511W108

Newer quarter: Q3 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

PERCEPTIVE ADVISORS LLC

Disclosed value leader

PERCEPTIVE ADVISORS LLC

Comparable rows

0/15

Latest evidence

30 Sep 2019

13F Highest disclosed value: $50,337,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $50.34M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

PERCEPTIVE ADVISORS LLC $50.34M

ORBIMED ADVISORS LLC $21.84M

Fosun International Ltd $11.68M

BlackRock Finance, Inc. $10.26M

FMR LLC $9.23M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PERCEPTIVE ADVISORS LLC	13F Company 13F	— denominator unverified	$50,337,000 3,410,412 shares	—	30 Sep 2019
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$21,841,000 1,479,733 shares	—	30 Sep 2019
Fosun International Ltd	13F Company 13F	— denominator unverified	$11,681,000 791,412 shares	—	30 Sep 2019
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$10,261,000 695,253 shares	—	30 Sep 2019
FMR LLC	13F Company 13F	— denominator unverified	$9,234,000 625,630 shares	—	30 Sep 2019
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$8,024,000 543,639 shares	—	30 Sep 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

9,202,752

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2019 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2019 holders

Holder diff

Investor	Q3 2025 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2025 value	Q4 2019 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend